Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Ford Investor Services, Inc.
$12.00
Provider: Thomson Reuters StreetEvents
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Aerie Pharmaceuticals Inc Announces Pricing of Initial Public Offering


Friday, 25 Oct 2013 06:30am EDT 

Aerie Pharmaceuticals, Inc announced the pricing of its initial public offering of 6,720,000 shares of its common stock at a public offering price of $10.00 per share, before underwriting discounts. The shares are scheduled to begin trading on the NASDAQ Global Market on October 25, 2013 under the ticker symbol 'AERI.' In addition, Aerie has granted the underwriters a 30-day option to purchase up to an additional 1,008,000 shares of common stock at the same price to cover over-allotments, if any. The offering is expected to close on October 30, 2013, subject to customary closing conditions. RBC Capital Markets and Stifel are serving as joint book-running managers for the offering. Canaccord Genuity Inc. and Needham & Company are serving as co-managers.